[1]
T. Biya, H. Sanusi, and A. M. Aman, “High Remnant Cholesterol Increased the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) or Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis”, J ASEAN Fed Endocr Soc, vol. 41, no. 1, pp. 162–169, Apr. 2026.